Sudden cardiac death in patients with nonischemic cardiomyopathy

Brian P Betensky1, Sanjay Dixit2

  • 1Division of Cardiac Electrophysiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.

Indian Heart Journal
|February 27, 2014
PubMed

Insights

Sudden cardiac death (SCD) risk is significant in nonischemic cardiomyopathies. This review explores the substrate for ventricular arrhythmias and SCD risk factors in dilated, hypertrophic, and arrhythmogenic right ventricular cardiomyopathies.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Sudden Cardiac Death Research

Background:

  • Sudden cardiac death (SCD) is a major global health concern.
  • While often linked to coronary heart disease, SCD risk is also significant in patients without ischemic heart disease.
  • Nonischemic cardiomyopathies, including dilated, hypertrophic, and arrhythmogenic right ventricular types, are strongly associated with SCD and ventricular arrhythmias.

Purpose of the Study:

  • To review the current understanding of the arrhythmogenic substrate in nonischemic cardiomyopathies.
  • To highlight features associated with increased SCD risk in these conditions.
  • To discuss challenges in risk stratification and treatment of ventricular arrhythmias.

Main Methods:

  • Literature review of studies on nonischemic cardiomyopathies and SCD.
  • Analysis of anatomic and electrophysiologic substrates for ventricular arrhythmias.
  • Evaluation of risk stratification tools and clinical features.

Main Results:

  • Nonischemic cardiomyopathies present unique challenges for identifying SCD risk.
  • Understanding the specific substrate in each cardiomyopathy is crucial for risk assessment.
  • Optimal risk stratification strategies remain an area of active investigation.

Conclusions:

  • Ventricular arrhythmias and SCD are significant risks in nonischemic cardiomyopathies.
  • Further research is needed to refine risk stratification and management strategies.
  • Targeted approaches to the arrhythmogenic substrate may improve outcomes.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
620
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
565
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
645